{"id":"W3118976699","doi":"10.1007/s10637-020-01043-9","title":"The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial","year":2021,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Fondation du cancer des Cèdres; Frank McGraw Memorial Chair in Cancer Research","keywords":"Pembrolizumab; Ovary; Medicine; Clinical trial; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001899948,0.0001419829,0.0003420509,0.00002769457,0.0001141489,0.0000124184,0.0000620283,0.00004801585,0.00004081915],"category_scores_gemma":[0.0002587549,0.0000804391,0.00009430473,0.0002167746,0.0003476885,0.00005068272,0.00007387556,0.0001489266,6.282526e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007156566,"about_ca_system_score_gemma":0.0009865673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002595556,"about_ca_topic_score_gemma":0.0001781204,"domain_scores_codex":[0.9983734,0.00019707,0.0006400282,0.0002677986,0.0003964704,0.0001252031],"domain_scores_gemma":[0.9985499,0.0005697549,0.0002845996,0.0002972886,0.0001432534,0.0001551737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2115416,0.02728388,0.6901304,0.0002311837,0.001032155,0.0006987948,0.008500746,0.00008420213,0.0002890185,0.002217757,0.006417112,0.05157324],"study_design_scores_gemma":[0.3312985,0.006425033,0.6505957,0.001008991,0.000549686,0.0000841639,0.0002926353,0.00003911065,0.004475878,0.001401625,0.003619109,0.00020955],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925253,0.0004377851,0.000001613905,0.005698724,0.0002126717,0.0007634119,0.0002756554,0.000005036373,0.00007982461],"genre_scores_gemma":[0.9988025,0.00006165283,0.0005509371,0.0002339205,0.0001096228,0.00002187849,0.0001576816,0.000009934243,0.0000518404],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1197569,"threshold_uncertainty_score":0.3280211,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02975482929178661,"score_gpt":0.2904753696380554,"score_spread":0.2607205403462688,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}